|
Drug Design News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
- Receptos Completes $25M Series A Financing 23 Nov 2009 13:31 GMT
... Receptos will initially target the Edg family of receptor proteins, including S1P1, for structure-based drug design. The company will also expand efforts into additional, select high-value GPCR targets independently and ...
- Receptos Raises $25M in Series A Financing 23 Nov 2009 16:33 GMT
... Receptos is initially targeting the Edg family of receptor proteins, including S1P1, for structure-based drug design. The company hopes to expand its GPCR R&D both in-house and through industry partnerships, ...
- BioCryst Announces Pricing of Public Offering of Common Stock 23 Nov 2009 05:12 GMT
... purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early ...
- New Link Discovered Between Insulin And Core Body Temperature 23 Nov 2009 08:40 GMT
... temperature may play a role in and may represent a therapeutic area in future drug design," added Osborn. The laboratory of Tamas Bartfai, who is chair of the Department of ...
- Insulin and core body temperature linked 23 Nov 2009 20:33 GMT
... may play a role in obesity and may represent a therapeutic area in future drug design. The research recently appeared in the online edition of the journal Diabetes and is ...
- Scholarships for minority chemistry students available from American Chemical Society 23 Nov 2009 22:33 GMT
... chemistry you can change the world. “Whether you apply that degree to medicine and drug design, environmental studies, forensics, food, the search for alternate energy sources, safeguarding national security, or ...
- BUYINS.NET: LGCFF, HSOA, ABMC, CHIO, BCRX, BANR Have Been Added To Naked Short Lists Today 18 Nov 2009 16:57 GMT
... block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to ...
- Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association 18 Nov 2009 05:11 GMT
... eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of these original drugs ...
- Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association (BIZ) 18 Nov 2009 05:30 GMT
... eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of these original drugs ...
- The Great Reaction 21 Nov 2009 06:24 GMT
... small chemical building blocks to form far more complex structures. If his concept works, drug design will become a bit like building with Legos. Chemists could rapidly create new drugs ...
- Xconomy discusses Ambit history, upcoming clinical program with CEO Scott Salka 21 Nov 2009 04:32 GMT
... Manager of SPR for Fujifilm Life Science USA, about the current state of fragment-based drug design and how it is affecting everyone from big pharma to academia. Frost & Sullivan’s ...
- Scripps research scientists find new link between insulin and core body temperature 19 Nov 2009 20:13 GMT
... may play a role in obesity and may represent a therapeutic area in future drug design," added Osborn. The laboratory of Tamas Bartfai, who is chair of the Department of ...
- Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources 20 Nov 2009 16:51 GMT
... interference (RNAi), microRNA, large molecules, biologics, glycosylation, antisense, oligonucleotides, DNA vaccine immunotherapy, structure based drug design, deuterium-based drugs. -- Industry outlook: Restructuring internal R&D, need for corporate partnerships, reallocation of ...
- Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources (BIZ) 20 Nov 2009 16:55 GMT
... interference (RNAi), microRNA, large molecules, biologics, glycosylation, antisense, oligonucleotides, DNA vaccine immunotherapy, structure based drug design, deuterium-based drugs. -- Industry outlook: Restructuring internal R&D, need for corporate partnerships, reallocation of ...
- Selvita to Present a Poster on the Developments of Its Oncology Program During the 2009 AACR-NCI-EOR 19 Nov 2009 17:15 GMT
... The areas of our activity include: advanced protein modeling services and software; computer aided drug design; optimization of lead compounds; contract synthesis; information technology for research projects. Selvita also conducts ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
- CDC Reverses Gardasil Vaccine Requirement for Immigrants [21 Nov 2009 - 03:15]
- FDA actions in brief, November 2009 (FluMist, Cervarix, Gardasil, Fluarix, Folotyn, Micardis, Twynsta, Votrient, Mirena) [20 Nov 2009 - 17:02]
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women [20 Nov 2009 - 04:58]
- FDA Approves Gardasil for Genital Warts in Men and Boys [19 Nov 2009 - 16:02]
Pharmaceutical Industry Today
|
a digital news provider
reuters.com:
healthday.com:
aboutlawsuits.com:
wsj.com: